New Owner
Cephalon - ChemGenex Pharmaceuticals
Cephalon acquires ChemGenex Pharmaceuticals
Announced: March 29, 2011
Type: Acquisition
Disposition: Subsidiary
Terms: Cash & Stock
Status: Complete
Amount: $ 225,000,000